Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Earnings
Notable companies reporting before tomorrow's open » 20:25
10/26/21
10/26
20:25
10/26/21
20:25
TMO

Thermo Fisher

$608.25 /

+0.63 (+0.10%)

, KO

Coca-Cola

$54.46 /

+0.23 (+0.42%)

, MCD

McDonald's

$236.38 /

-0.96 (-0.40%)

, BMY

Bristol-Myers

$58.24 /

+0.47 (+0.81%)

, BA

Boeing

$209.77 /

-3.19 (-1.50%)

, GM

General Motors

$57.36 /

-0.38 (-0.66%)

, FISV

Fiserv

$109.87 /

-1.22 (-1.10%)

, BSX

Boston Scientific

$44.32 /

-0.17 (-0.38%)

, GD

General Dynamics

$204.47 /

-3.42 (-1.65%)

, KHC

Kraft Heinz

$36.44 /

+0.25 (+0.69%)

, HLT

Hilton

$144.40 /

+2.245 (+1.58%)

, DT

Dynatrace

$77.74 /

-0.09 (-0.12%)

, IP

International Paper

$53.04 /

+0.05 (+0.09%)

, NYCB

New York Community Bancorp

$13.94 /

-0.02 (-0.14%)

, HOG

Harley-Davidson

$35.45 /

-1.51 (-4.09%)

, SIX

Six Flags

$46.16 /

+0.03 (+0.07%)

Notable companies…

Notable companies reporting before tomorrow's open, with earnings consensus, include Thermo Fisher (TMO), consensus $4.67... Coca-Cola (KO), consensus 58c... McDonald's (MCD), consensus $2.46... Bristol Myers (BMY), consensus $1.92... Boeing (BA), consensus (21c)... General Motors (GM), consensus 96c... Fiserv (FISV), consensus $1.45... Boston Scientific (BSX), consensus 40c... General Dynamics (GD), consensus $2.98... Kraft Heinz (KHC), consensus 58c... Hilton Worldwide (HLT), consensus 85c... Dynatrace (DT), consensus 16c... International Paper (IP), consensus $1.45... New York Community Bancorp (NYCB), consensus 32c... Harley-Davidson (HOG), consensus 70c... Six Flags (SIX), consensus $1.55.

ShowHide Related Items >><<
TMO Thermo Fisher
$608.25 /

+0.63 (+0.10%)

SIX Six Flags
$46.16 /

+0.03 (+0.07%)

NYCB New York Community Bancorp
$13.94 /

-0.02 (-0.14%)

MCD McDonald's
$236.38 /

-0.96 (-0.40%)

KO Coca-Cola
$54.46 /

+0.23 (+0.42%)

KHC Kraft Heinz
$36.44 /

+0.25 (+0.69%)

IP International Paper
$53.04 /

+0.05 (+0.09%)

HOG Harley-Davidson
$35.45 /

-1.51 (-4.09%)

HLT Hilton
$144.40 /

+2.245 (+1.58%)

GM General Motors
$57.36 /

-0.38 (-0.66%)

GD General Dynamics
$204.47 /

-3.42 (-1.65%)

FISV Fiserv
$109.87 /

-1.22 (-1.10%)

DT Dynatrace
$77.74 /

-0.09 (-0.12%)

BSX Boston Scientific
$44.32 /

-0.17 (-0.38%)

BMY Bristol-Myers
$58.24 /

+0.47 (+0.81%)

BA Boeing
$209.77 /

-3.19 (-1.50%)

TMO Thermo Fisher
$608.25 /

+0.63 (+0.10%)

10/20/21
Fly Intel: Top five analyst upgrades
10/20/21 Citi
Citi upgrades Thermo Fisher to Buy, says discount unwarranted
10/20/21 Citi
Thermo Fisher upgraded to Buy from Neutral at Citi
10/14/21 Cowen
Thermo Fisher price target raised to $696 from $655 at Cowen
KO Coca-Cola
$54.46 /

+0.23 (+0.42%)

10/15/21 Deutsche Bank
Coca-Cola price target lowered to $59 from $60 at Deutsche Bank
09/21/21 Guggenheim
PepsiCo price target raised to $175 from $171 at Guggenheim
07/22/21 Truist
Coca-Cola price target raised to $65 from $60 at Truist
07/22/21 Deutsche Bank
Coca-Cola price target raised to $60 from $58 at Deutsche Bank
MCD McDonald's
$236.38 /

-0.96 (-0.40%)

10/14/21 Wells Fargo
McDonald's price target raised to $276 from $269 at Wells Fargo
10/05/21 Loop Capital
McDonald's initiated with a Buy at Loop Capital
10/05/21 Deutsche Bank
McDonald's price target raised to $265 ahead of Q3 at Deutsche Bank
10/05/21 Piper Sandler
Piper teen survey shows clothing outranked food for first time since 2014
BMY Bristol-Myers
$58.24 /

+0.47 (+0.81%)

10/26/21 RBC Capital
Aurinia Pharmaceuticals price target raised to $34 from $23 at RBC Capital
10/25/21 SVB Leerink
Potential Bristol takeover of Aurinia makes strategic sense, says SVB Leerink
10/25/21 Citi
Bristol-Myers report of Aurinia approach 'looks credible,' says Citi
10/12/21 Morgan Stanley
Bristol-Myers price target lowered to $66 from $71 at Morgan Stanley
BA Boeing
$209.77 /

-3.19 (-1.50%)

10/21/21 RBC Capital
Ducommun initiated with an Outperform at RBC Capital
10/21/21 RBC Capital
Spirit AeroSystems initiated with an Outperform at RBC Capital
10/21/21 RBC Capital
RBC starts Boeing at Outperform, sees attractive entry point
10/21/21 RBC Capital
Boeing initiated with an Outperform at RBC Capital
GM General Motors
$57.36 /

-0.38 (-0.66%)

10/25/21 Wedbush
Hertz mega deal another 'feather in the cap' for Tesla, says Wedbush
10/22/21 Barclays
General Motors price target raised to $70 from $68 at Barclays
10/21/21 JPMorgan
General Motors price target raised to $80 from $77 at JPMorgan
10/18/21 Bernstein
Bernstein still 'struggles' with Tesla stock valuation
FISV Fiserv
$109.87 /

-1.22 (-1.10%)

09/30/21
Fly Intel: Top five analyst initiations
09/30/21 William Blair
William Blair assumes Fiserv at Outperform on double-digit earnings growth
09/30/21 William Blair
Fiserv assumed with an Outperform at William Blair
08/19/21 Truist
ValueAct's reported SOTP argument for Fiserv 'doesn't hold water,' says Truist
BSX Boston Scientific
$44.32 /

-0.17 (-0.38%)

10/06/21 Piper Sandler
Boston Scientific acquisition of Baylis looks 'solid,' says Piper Sandler
09/22/21 Piper Sandler
Boston Scientific said unlikely to hit low end of Q3 sales outlook, notes Piper
09/14/21 Piper Sandler
CMS full repeal proposal of MCIT negative for med tech, says Piper Sandler
08/31/21 BTIG
Abbott price target raised to $136 from $126 at BTIG
GD General Dynamics
$204.47 /

-3.42 (-1.65%)

09/23/21
Fly Intel: Top five analyst upgrades
09/23/21 Goldman Sachs
General Dynamics upgraded to Neutral from Sell at Goldman Sachs
09/21/21 Morgan Stanley
New AUKUS pact could benefit General Dynamics, Raytheon, says Morgan Stanley
07/29/21 Credit Suisse
General Dynamics price target raised to $198 from $182 at Credit Suisse
KHC Kraft Heinz
$36.44 /

+0.25 (+0.69%)

09/21/21 Morgan Stanley
Kraft Heinz assumed with an Equal Weight at Morgan Stanley
09/08/21 Stifel
Kraft Heinz outlines 'confident' view of business, says Stifel
08/20/21 Piper Sandler
Kraft Heinz price target lowered to $39 from $41 at Piper Sandler
05/05/21
Fly Intel: Top five analyst downgrades
HLT Hilton
$144.40 /

+2.245 (+1.58%)

10/05/21 Loop Capital
Hyatt initiated with a Hold at Loop Capital
10/05/21 Loop Capital
Hilton initiated with a Hold at Loop Capital
10/01/21 Jefferies
Hilton price target raised to $159 at Jefferies ahead of lodging earnings
08/02/21 Argus
Hilton price target raised to $154 from $145 at Argus
DT Dynatrace
$77.74 /

-0.09 (-0.12%)

10/22/21 BTIG
Dynatrace price target raised to $90 from $75 at BTIG
09/17/21 Barclays
Dynatrace price target raised to $85 from $75 at Barclays
08/04/21 BMO Capital
New Relic price target raised to $70 from $58 at BMO Capital
07/29/21 Truist
Dynatrace price target raised to $72 from $60 at Truist
IP International Paper
$53.04 /

+0.05 (+0.09%)

10/19/21 Exane BNP Paribas
International Paper downgraded to Neutral from Outperform at Exane BNP Paribas
10/13/21 KeyBanc
Containerboard capacity in North America could rise with new mill, says KeyBanc
10/12/21 Truist
Truist starts International Paper at Hold, sees containerboard cycle near peak
10/12/21 Truist
International Paper initiated with a Hold at Truist
NYCB New York Community Bancorp
$13.94 /

-0.02 (-0.14%)

10/01/21 B. Riley
New York Community shares 'should re-rate higher,' says B. Riley
05/04/21 Raymond James
Flagstar Bancorp downgraded to Market Perform from Strong Buy at Raymond James
05/03/21 Deutsche Bank
New York Community Bancorp price target raised to $15 from $11.50 at Deutsche Bank
04/27/21 Wedbush
Flagstar Bancorp downgraded to Neutral from Outperform at Wedbush
HOG Harley-Davidson
$35.45 /

-1.51 (-4.09%)

09/10/21 Tigress Financial
Harley-Davidson shares have 47% upside potential, says Tigress Financial
09/09/21 Wedbush
Harley-Davidson price target lowered to $54 from $60 at Wedbush
07/27/21 Edward Jones
Harley-Davidson downgraded to Sell from Hold at Edward Jones
07/22/21 Baird
Harley-Davidson demand drove inventory down, says Baird
SIX Six Flags
$46.16 /

+0.03 (+0.07%)

07/26/21 Wedbush
Six Flags upgraded to Outperform at Wedbush ahead of inflection in story
07/26/21 Wedbush
Six Flags upgraded to Outperform from Neutral at Wedbush
06/21/21 B. Riley
B. Riley sees further share upside in theme park stocks after visits
05/21/21 Stifel
Stifel ups price target for 'most compelling' theme park Six Flags to $59
TMO Thermo Fisher
$608.25 /

+0.63 (+0.10%)

SIX Six Flags
$46.16 /

+0.03 (+0.07%)

NYCB New York Community Bancorp
$13.94 /

-0.02 (-0.14%)

MCD McDonald's
$236.38 /

-0.96 (-0.40%)

KO Coca-Cola
$54.46 /

+0.23 (+0.42%)

KHC Kraft Heinz
$36.44 /

+0.25 (+0.69%)

IP International Paper
$53.04 /

+0.05 (+0.09%)

HOG Harley-Davidson
$35.45 /

-1.51 (-4.09%)

HLT Hilton
$144.40 /

+2.245 (+1.58%)

GM General Motors
$57.36 /

-0.38 (-0.66%)

GD General Dynamics
$204.47 /

-3.42 (-1.65%)

FISV Fiserv
$109.87 /

-1.22 (-1.10%)

DT Dynatrace
$77.74 /

-0.09 (-0.12%)

BSX Boston Scientific
$44.32 /

-0.17 (-0.38%)

BMY Bristol-Myers
$58.24 /

+0.47 (+0.81%)

BA Boeing
$209.77 /

-3.19 (-1.50%)

  • 30
    Apr
  • 10
    Dec
  • 09
    Dec
  • 10
    Nov
SIX Six Flags
$46.16 /

+0.03 (+0.07%)

MCD McDonald's
$236.38 /

-0.96 (-0.40%)

KO Coca-Cola
$54.46 /

+0.23 (+0.42%)

HLT Hilton
$144.40 /

+2.245 (+1.58%)

GM General Motors
$57.36 /

-0.38 (-0.66%)

GD General Dynamics
$204.47 /

-3.42 (-1.65%)

FISV Fiserv
$109.87 /

-1.22 (-1.10%)

BSX Boston Scientific
$44.32 /

-0.17 (-0.38%)

BMY Bristol-Myers
$58.24 /

+0.47 (+0.81%)

BA Boeing
$209.77 /

-3.19 (-1.50%)

TMO Thermo Fisher
$608.25 /

+0.63 (+0.10%)

SIX Six Flags
$46.16 /

+0.03 (+0.07%)

MCD McDonald's
$236.38 /

-0.96 (-0.40%)

KO Coca-Cola
$54.46 /

+0.23 (+0.42%)

KHC Kraft Heinz
$36.44 /

+0.25 (+0.69%)

IP International Paper
$53.04 /

+0.05 (+0.09%)

HOG Harley-Davidson
$35.45 /

-1.51 (-4.09%)

HLT Hilton
$144.40 /

+2.245 (+1.58%)

GM General Motors
$57.36 /

-0.38 (-0.66%)

GD General Dynamics
$204.47 /

-3.42 (-1.65%)

FISV Fiserv
$109.87 /

-1.22 (-1.10%)

DT Dynatrace
$77.74 /

-0.09 (-0.12%)

BSX Boston Scientific
$44.32 /

-0.17 (-0.38%)

BMY Bristol-Myers
$58.24 /

+0.47 (+0.81%)

BA Boeing
$209.77 /

-3.19 (-1.50%)

TMO Thermo Fisher
$608.25 /

+0.63 (+0.10%)

MCD McDonald's
$236.38 /

-0.96 (-0.40%)

KO Coca-Cola
$54.46 /

+0.23 (+0.42%)

KHC Kraft Heinz
$36.44 /

+0.25 (+0.69%)

IP International Paper
$53.04 /

+0.05 (+0.09%)

HOG Harley-Davidson
$35.45 /

-1.51 (-4.09%)

HLT Hilton
$144.40 /

+2.245 (+1.58%)

GM General Motors
$57.36 /

-0.38 (-0.66%)

FISV Fiserv
$109.87 /

-1.22 (-1.10%)

BSX Boston Scientific
$44.32 /

-0.17 (-0.38%)

BMY Bristol-Myers
$58.24 /

+0.47 (+0.81%)

BA Boeing
$209.77 /

-3.19 (-1.50%)

Hot Stocks
Pfizer, BioNTech confirm FDA panel supports EUA for COVID vaccine in children » 18:20
10/26/21
10/26
18:20
10/26/21
18:20
PFE

Pfizer

$43.56 /

+0.39 (+0.90%)

, BNTX

BioNTech

$292.41 /

-2.63 (-0.89%)

Pfizer (PFE) and BioNTech…

Pfizer (PFE) and BioNTech (BNTX) announced that the U.S. Food and Drug Administration's Vaccines and Related Biological Products Advisory Committee voted 17 to 0, with 1 abstention, to recommend the FDA grant Emergency Use Authorization for the companies' COVID-19 vaccine in children 5 to less than12 years of age. VRBPAC is made up of independent experts who advise the FDA on scientific and regulatory matters, including the evaluation of vaccine safety and efficacy. The committee reviewed the totality of scientific evidence shared by the companies, including results from a Phase 2/3 randomized, controlled trial that included ~4,500 children 5 to less than12 years of age. Participants in this age group received a two-dose regimen of 10-microgram doses administered 21 days apart, one-third of the 30-microgram dose used for people 12 years and older. This dose level was carefully selected for use in the trial based on safety, tolerability and immunogenicity data evaluated as part of a dose-ranging study. The Phase 2/3 trial showed a favorable safety profile, robust immune responses and a vaccine efficacy rate of 90.7% in participants without prior SARS-CoV-2 infection, measured from 7 days after the second dose. The Data Monitoring Committee for the study has reviewed the data and has not identified any serious safety concerns related to the vaccine. "We appreciated the opportunity to present our clinical data demonstrating the safety and high efficacy of our COVID-19 vaccine in children 5 to under 12 years of age," said Kathrin U. Jansen, Ph.D., Senior Vice President and Head of Vaccine Research & Development, Pfizer. "COVID-19 is an ongoing threat for the more than 28 million young children in this age group in the U.S., as they remain at risk for this infection. About 10% of all weekly U.S. cases occur in children 5 to under 12 years of age with a potential risk of complications. In addition, immunizing children will help to get us closer to herd immunity, with the potential to stem the pandemic sooner. We thank the FDA advisory committee for their review and positive recommendation in support of Emergency Use Authorization to help protect this young population."

ShowHide Related Items >><<
PFE Pfizer
$43.56 /

+0.39 (+0.90%)

BNTX BioNTech
$292.41 /

-2.63 (-0.89%)

PFE Pfizer
$43.56 /

+0.39 (+0.90%)

10/15/21 H.C. Wainwright
H.C. Wainwright ups Codexis target, says Pfizer pact may be growth driver
10/14/21 Craig-Hallum
Craig-Hallum keeps Buy rating on Codexis after today's curve ball'
10/14/21 Stifel
Codexis' large order being from Pfizer, not Merck, a 'plot twist,' says Stifel
10/12/21 Morgan Stanley
Pfizer price target raised to $48 from $45 at Morgan Stanley
BNTX BioNTech
$292.41 /

-2.63 (-0.89%)

10/22/21
Fly Intel: Top five analyst initiations
10/22/21 Deutsche Bank
BioNTech initiated with a Hold at Deutsche Bank
10/06/21 Jefferies
BioNTech initiated with a Hold at Jefferies
09/24/21 Morgan Stanley
Morgan Stanley says CDC call 'modest narrowing' of Pfizer booster recommendation
PFE Pfizer
$43.56 /

+0.39 (+0.90%)

BNTX BioNTech
$292.41 /

-2.63 (-0.89%)

PFE Pfizer
$43.56 /

+0.39 (+0.90%)

BNTX BioNTech
$292.41 /

-2.63 (-0.89%)

PFE Pfizer
$43.56 /

+0.39 (+0.90%)

PFE Pfizer
$43.56 /

+0.39 (+0.90%)

Hot Stocks
Twitter says it's moving fast to adapt to Apple tracking changes » 18:17
10/26/21
10/26
18:17
10/26/21
18:17
TWTR

Twitter

$61.40 /

-0.71 (-1.14%)

, AAPL

Apple

$149.26 /

+0.6 (+0.40%)

Twitter (TWTR) says…

Twitter (TWTR) says moving fast to adapt to Apple (AAPL) tracking changes. Says has "so much more work to do" in terms of machine learning.

ShowHide Related Items >><<
TWTR Twitter
$61.40 /

-0.71 (-1.14%)

AAPL Apple
$149.26 /

+0.6 (+0.40%)

TWTR Twitter
$61.40 /

-0.71 (-1.14%)

10/24/21 BofA
Twitter price target lowered to $82 from $90 at BofA
10/22/21 Piper Sandler
Snap results raise uncertainty for digital advertising, says Piper Sandler
10/18/21 Wedbush
Wedbush continues to favor Google, Snap headed into quarterly results
10/07/21 Oppenheimer
AppLovin price target raised to $95 from $75 at Oppenheimer
AAPL Apple
$149.26 /

+0.6 (+0.40%)

10/26/21 Truist
Facebook price target lowered to $400 from $425 at Truist
10/26/21 Oppenheimer
Oppenheimer keeps Outperform, $405 target on Facebook after quarterly results
10/26/21 Wedbush
Facebook price target lowered to $325 from $355 at Wedbush
10/26/21 Craig-Hallum
Magnite price target lowered to $45 from $52 at Craig-Hallum
TWTR Twitter
$61.40 /

-0.71 (-1.14%)

AAPL Apple
$149.26 /

+0.6 (+0.40%)

TWTR Twitter
$61.40 /

-0.71 (-1.14%)

AAPL Apple
$149.26 /

+0.6 (+0.40%)

TWTR Twitter
$61.40 /

-0.71 (-1.14%)

AAPL Apple
$149.26 /

+0.6 (+0.40%)

TWTR Twitter
$61.40 /

-0.71 (-1.14%)

AAPL Apple
$149.26 /

+0.6 (+0.40%)

AAPL Apple
$149.26 /

+0.6 (+0.40%)

Hot Stocks
Twitter not changing goal of generating $7B+ in annual revenue by 2023 » 18:11
10/26/21
10/26
18:11
10/26/21
18:11
TWTR

Twitter

$61.40 /

-0.71 (-1.14%)

, AAPL

Apple

$149.26 /

+0.6 (+0.40%)

Twitter (TWTR) says 12 of…

Twitter (TWTR) says 12 of 14 official Olympics sponsors ran ads on Twitter during 2021 games. Says no change to goal of generating $7B or more in annual revenue by 2023. Says too early to assess overall impact of Apple's (AAPL) App Store changes, but notes "modest" impact in Q3. Comments taken from Q3 earnings conference call.

ShowHide Related Items >><<
TWTR Twitter
$61.40 /

-0.71 (-1.14%)

AAPL Apple
$149.26 /

+0.6 (+0.40%)

TWTR Twitter
$61.40 /

-0.71 (-1.14%)

10/24/21 BofA
Twitter price target lowered to $82 from $90 at BofA
10/22/21 Piper Sandler
Snap results raise uncertainty for digital advertising, says Piper Sandler
10/18/21 Wedbush
Wedbush continues to favor Google, Snap headed into quarterly results
10/07/21 Oppenheimer
AppLovin price target raised to $95 from $75 at Oppenheimer
AAPL Apple
$149.26 /

+0.6 (+0.40%)

10/26/21 Truist
Facebook price target lowered to $400 from $425 at Truist
10/26/21 Oppenheimer
Oppenheimer keeps Outperform, $405 target on Facebook after quarterly results
10/26/21 Wedbush
Facebook price target lowered to $325 from $355 at Wedbush
10/26/21 Craig-Hallum
Magnite price target lowered to $45 from $52 at Craig-Hallum
TWTR Twitter
$61.40 /

-0.71 (-1.14%)

AAPL Apple
$149.26 /

+0.6 (+0.40%)

TWTR Twitter
$61.40 /

-0.71 (-1.14%)

AAPL Apple
$149.26 /

+0.6 (+0.40%)

TWTR Twitter
$61.40 /

-0.71 (-1.14%)

AAPL Apple
$149.26 /

+0.6 (+0.40%)

TWTR Twitter
$61.40 /

-0.71 (-1.14%)

AAPL Apple
$149.26 /

+0.6 (+0.40%)

AAPL Apple
$149.26 /

+0.6 (+0.40%)

Hot Stocks
Trillium shareholders approve acquisition by Pfizer subsidiary » 17:16
10/26/21
10/26
17:16
10/26/21
17:16
TRIL

Trillium Therapeutics

$17.97 /

+0.055 (+0.31%)

, PFE

Pfizer

$43.56 /

+0.39 (+0.90%)

Trillium Therapeutics…

Trillium Therapeutics (TRIL) announced that its securityholders approved a statutory arrangement with PF Argentum, a wholly-owned, indirect subsidiary of Pfizer (PFE) at the special meeting of Trillium securityholders. Pursuant to the arrangement, PF Argentum will acquire all of the issued and outstanding shares and warrants of Trillium, other than Trillium securities owned by Pfizer and its affiliates. The arrangement is subject to court and regulatory approvals and clearances, as well as other customary closing conditions. Subject to the satisfaction of such conditions, the transaction is expected to be completed in Q4 of 2021 or the first half of 2022.

ShowHide Related Items >><<
TRIL Trillium Therapeutics
$17.97 /

+0.055 (+0.31%)

PFE Pfizer
$43.56 /

+0.39 (+0.90%)

TRIL Trillium Therapeutics
$17.97 /

+0.055 (+0.31%)

08/24/21 Craig-Hallum
Trillium Therapeutics downgraded to Hold at Craig-Hallum
08/24/21 Craig-Hallum
Trillium Therapeutics downgraded to Hold from Buy at Craig-Hallum
08/24/21 JMP Securities
Trillium downgraded to Market Perform from Outperform at JMP Securities
08/23/21
Fly Intel: Top five analyst downgrades
PFE Pfizer
$43.56 /

+0.39 (+0.90%)

10/15/21 H.C. Wainwright
H.C. Wainwright ups Codexis target, says Pfizer pact may be growth driver
10/14/21 Craig-Hallum
Craig-Hallum keeps Buy rating on Codexis after today's curve ball'
10/14/21 Stifel
Codexis' large order being from Pfizer, not Merck, a 'plot twist,' says Stifel
10/12/21 Morgan Stanley
Pfizer price target raised to $48 from $45 at Morgan Stanley
TRIL Trillium Therapeutics
$17.97 /

+0.055 (+0.31%)

PFE Pfizer
$43.56 /

+0.39 (+0.90%)

PFE Pfizer
$43.56 /

+0.39 (+0.90%)

TRIL Trillium Therapeutics
$17.97 /

+0.055 (+0.31%)

PFE Pfizer
$43.56 /

+0.39 (+0.90%)

TRIL Trillium Therapeutics
$17.97 /

+0.055 (+0.31%)

PFE Pfizer
$43.56 /

+0.39 (+0.90%)

Hot Stocks
EVgo, GM open new EV charging station in Colorado » 16:28
10/26/21
10/26
16:28
10/26/21
16:28
EVGO

EVgo

$8.29 /

-0.315 (-3.66%)

, GM

General Motors

$57.36 /

-0.38 (-0.66%)

EVgo (EVGO) announced the…

EVgo (EVGO) announced the opening of a new EV charging station comprised of six new EVgo public direct current fast chargers at Lloyd King Center, located at 6350 Sheridan Boulevard in Arvada, Colorado. "The opening of another EVgo charging station in Colorado builds upon GM (GM) and EVgo's effort to accelerate charging infrastructure build out by adding more than 2,700 DC fast charging stations. Along with all the Ultium-ready chargers at EVgo stations, GM customers can leverage charging capabilities up to 350-kilowatts," said Alex Keros, Lead Architect, EV Infrastructure at General Motors. "We are excited to partner with EVgo to expand charging access here in the Rocky Mountain State and across the country."

ShowHide Related Items >><<
GM General Motors
$57.36 /

-0.38 (-0.66%)

EVGO EVgo
$8.29 /

-0.315 (-3.66%)

EVGO EVgo
$8.29 /

-0.315 (-3.66%)

09/21/21 Credit Suisse
EVgo initiated with an Outperform at Credit Suisse
09/15/21
Fly Intel: Top five analyst initiations
09/15/21 Citi
EVgo initiated with a Neutral at Citi
08/30/21 BofA
EVgo initiated with a Neutral at BofA
GM General Motors
$57.36 /

-0.38 (-0.66%)

10/25/21 Wedbush
Hertz mega deal another 'feather in the cap' for Tesla, says Wedbush
10/22/21 Barclays
General Motors price target raised to $70 from $68 at Barclays
10/21/21 JPMorgan
General Motors price target raised to $80 from $77 at JPMorgan
10/18/21 Bernstein
Bernstein still 'struggles' with Tesla stock valuation
GM General Motors
$57.36 /

-0.38 (-0.66%)

GM General Motors
$57.36 /

-0.38 (-0.66%)

EVGO EVgo
$8.29 /

-0.315 (-3.66%)

GM General Motors
$57.36 /

-0.38 (-0.66%)

EVGO EVgo
$8.29 /

-0.315 (-3.66%)

GM General Motors
$57.36 /

-0.38 (-0.66%)

EVGO EVgo
$8.29 /

-0.315 (-3.66%)

Hot Stocks
FDA panel votes in support of Pfizer-BioNTech vaccine for kids aged 5-11 » 16:19
10/26/21
10/26
16:19
10/26/21
16:19
PFE

Pfizer

$43.56 /

+0.39 (+0.90%)

, BNTX

BioNTech

$292.41 /

-2.63 (-0.89%)

An FDA Advisory Committee…

An FDA Advisory Committee voted 17 yes to 0 no with 1 abstention that the totality of scientific evidence available supports the benefits of the Pfizer (PFE) and BioNTech (BNTX) COVID vaccine when administered as a 2-dose series outweigh its risks for use in children 5-11 years of age.

ShowHide Related Items >><<
PFE Pfizer
$43.56 /

+0.39 (+0.90%)

BNTX BioNTech
$292.41 /

-2.63 (-0.89%)

PFE Pfizer
$43.56 /

+0.39 (+0.90%)

10/15/21 H.C. Wainwright
H.C. Wainwright ups Codexis target, says Pfizer pact may be growth driver
10/14/21 Craig-Hallum
Craig-Hallum keeps Buy rating on Codexis after today's curve ball'
10/14/21 Stifel
Codexis' large order being from Pfizer, not Merck, a 'plot twist,' says Stifel
10/12/21 Morgan Stanley
Pfizer price target raised to $48 from $45 at Morgan Stanley
BNTX BioNTech
$292.41 /

-2.63 (-0.89%)

10/22/21
Fly Intel: Top five analyst initiations
10/22/21 Deutsche Bank
BioNTech initiated with a Hold at Deutsche Bank
10/06/21 Jefferies
BioNTech initiated with a Hold at Jefferies
09/24/21 Morgan Stanley
Morgan Stanley says CDC call 'modest narrowing' of Pfizer booster recommendation
PFE Pfizer
$43.56 /

+0.39 (+0.90%)

BNTX BioNTech
$292.41 /

-2.63 (-0.89%)

PFE Pfizer
$43.56 /

+0.39 (+0.90%)

BNTX BioNTech
$292.41 /

-2.63 (-0.89%)

PFE Pfizer
$43.56 /

+0.39 (+0.90%)

PFE Pfizer
$43.56 /

+0.39 (+0.90%)

Hot Stocks
Apple News expands local news offerings » 16:03
10/26/21
10/26
16:03
10/26/21
16:03
AAPL

Apple

$149.83 /

+1.17 (+0.79%)

Apple announced that…

Apple announced that Apple News will now offer its local news experience in three additional cities in the U.S., namely Charlotte, Miami, and Washington, D.C. "Each experience is curated by Apple News editors and features coverage of topics that are important to local communities, from restaurant openings and real estate trends to big policy decisions. Local news offerings in Apple News provide readers with access to top publications, including Axios Charlotte, the Charlotte Observer, Eater Miami, the Miami Herald, DCist, Washingtonian, the Washington Post, and more," according to the company. Apple News first introduced curated local news experiences for the Bay Area, Houston, Los Angeles, New York, and San Francisco in 2020, and earlier this year, added offerings for Sacramento, San Antonio, and San Diego. Apple News plans to expand its local news feature to additional cities and regions over time. Reference Link

ShowHide Related Items >><<
AAPL Apple
$149.83 /

+1.17 (+0.79%)

AAPL Apple
$149.83 /

+1.17 (+0.79%)

10/26/21 Truist
Facebook price target lowered to $400 from $425 at Truist
10/26/21 Oppenheimer
Oppenheimer keeps Outperform, $405 target on Facebook after quarterly results
10/26/21 Wedbush
Facebook price target lowered to $325 from $355 at Wedbush
10/26/21 Craig-Hallum
Magnite price target lowered to $45 from $52 at Craig-Hallum
AAPL Apple
$149.83 /

+1.17 (+0.79%)

AAPL Apple
$149.83 /

+1.17 (+0.79%)

AAPL Apple
$149.83 /

+1.17 (+0.79%)

AAPL Apple
$149.83 /

+1.17 (+0.79%)

AAPL Apple
$149.83 /

+1.17 (+0.79%)

Periodicals
FCA close to plea deal in U.S. emissions fraud investigation, Reuters says » 15:49
10/26/21
10/26
15:49
10/26/21
15:49
STLA

Stellantis

$20.36 /

-0.01 (-0.05%)

Fiat Chrysler is close to…

Fiat Chrysler is close to a deal to plead guilty to criminal conduct to settle a multiyear emissions fraud investigation surrounding Ram pickup trucks and Jeep SUVs with diesel engines, Reuters' Mike Spector and David Shepardson report, citing people familiar with the matter. FCA lawyers and DOJ officials are working on a plea deal that could be announced in coming weeks and include financial penalties of $250M-$300M, the authors say. FCA is now part of Stellantis, The Fly notes. Reference Link

ShowHide Related Items >><<
STLA Stellantis
$20.36 /

-0.01 (-0.05%)

STLA Stellantis
$20.36 /

-0.01 (-0.05%)

09/07/21 KeyBanc
Jeep micro site on Amazon points to auto sales moving online, says KeyBanc
09/03/21 Deutsche Bank
Stellantis deal 'significant opportunity' for Open Lending, says Deutsche Bank
09/02/21 DA Davidson
DA Davidson says Stellantis opportunity for Open Lending not 'fait accompli'
09/02/21 Raymond James
Raymond James says buy Open Lending aggressively after Stellantis deal
STLA Stellantis
$20.36 /

-0.01 (-0.05%)

STLA Stellantis
$20.36 /

-0.01 (-0.05%)

STLA Stellantis
$20.36 /

-0.01 (-0.05%)

Periodicals
GM to resume Chevy Bolt output at Orion plant November 1, Reuters says » 14:01
10/26/21
10/26
14:01
10/26/21
14:01
GM

General Motors

$57.38 /

-0.36 (-0.62%)

General Motors said it…

General Motors said it plans to resume limited output for two weeks at its Orion factory in Michigan, which has been closed since August and manufactures the Chevrolet Bolt, Reuters' David Shepardson reports. The plant is idled through the end of this month, and the car maker said the limited production will begin November 1 to help optimize battery production and supply chain repair logistics, the author notes. Reference Link

ShowHide Related Items >><<
GM General Motors
$57.38 /

-0.36 (-0.62%)

GM General Motors
$57.38 /

-0.36 (-0.62%)

10/25/21 Wedbush
Hertz mega deal another 'feather in the cap' for Tesla, says Wedbush
10/22/21 Barclays
General Motors price target raised to $70 from $68 at Barclays
10/21/21 JPMorgan
General Motors price target raised to $80 from $77 at JPMorgan
10/18/21 Bernstein
Bernstein still 'struggles' with Tesla stock valuation
GM General Motors
$57.38 /

-0.36 (-0.62%)

GM General Motors
$57.38 /

-0.36 (-0.62%)

GM General Motors
$57.38 /

-0.36 (-0.62%)

GM General Motors
$57.38 /

-0.36 (-0.62%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.